Plant Comparison

Field restharrow vs Red Clover

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AField restharrowOnonis arvensisFabaceaeFull monograph →
Plant BRed CloverTrifolium pratenseFabaceaeFull monograph →

At a glance

Field restharrow and Red Clover: both belong to the Fabaceae family; they share 5 indicated uses (cancer (anticancer research), wounds, skin irritation, …); 6 pharmacological actions in common.

Field restharrowRed Clover
Constituents62
Pharmacological actions1210
Indicated uses1116
Safety notes32
Cited sources4244
Indicated uses
Only Field restharrow
Urinary supportUrinary tract infection (UTI)Kidney supportSwelling / fluid retentionInfection (general)Pain (general)
Shared (5)
Cancer (anticancer research)WoundsSkin irritationInflammation (general)Cardiovascular / heart health
Only Red Clover
Arthritis / joint painBronchitisCoughMenstrual crampsMuscle spasmRespiratory supportMenopauseHot flashesHigh cholesterolBlood sugar / diabetes supportCognitive function
Pharmacological actions
Only Field restharrow
DiureticUrinary antisepticAnalgesic (pain relief)GastroprotectiveAntifungalAntiplatelet / anticoagulant
Shared (6)
Anti-inflammatoryAntimicrobialVulnerary (wound healing)AntioxidantAnticancer (preclinical)Lipid-lowering
Only Red Clover
AntispasmodicExpectorantNeuroprotective / cognition supportAntidiabetic (blood-sugar lowering)

Evidence face-off — shared uses

ConditionField restharrowRed CloverVerdict
Cancer (anticancer research)2/107/10Stronger for Red Clover
Wounds2/107/10Stronger for Red Clover
Skin irritation2/105/10Stronger for Red Clover
Inflammation (general)2/105/10Stronger for Red Clover
Cardiovascular / heart health2/109/10Stronger for Red Clover

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Isoflavonoids (formononetin, ononin and derivatives)[1, 3, 5, 20]

Formononetin and its 7-O-glucoside ononin, plus related isoflavones - the signature restharrow constituents (also phytoestrogens).

FlavonoidsGlycosidesPhenolic compounds
Pterocarpans and isoflavanones (medicarpin, maackiain, onogenin, sativanone)[1, 4]

Pterocarpans and isoflavanones and their glucosides, contributing to antimicrobial and wound-healing activity.

FlavonoidsGlycosides
alpha-Onocerin[7]

alpha-Onocerin (onocerin), a characteristic triterpene of the genus Ononis.

Triterpene saponinsTerpenes / terpenoids
Coumarins (scopoletin, scopolin)[1]

Coumarins detected in the phytochemical profile.

Coumarins
Hydroxycinnamic / phenolic acids[6]

Caffeic, chlorogenic and p-coumaric acids (antioxidant).

Caffeic acidChlorogenic acidPhenolic acids
Essential (volatile) oil[10]

A volatile oil present in the root and aerial parts.

Essential (volatile) oil
Isoflavones (formononetin, biochanin A, daidzein, genistein)[14]

Phytoestrogenic isoflavones responsible for the plant's estrogenic and cardiovascular research interest; one of the richest known plant sources.

Flavonoids
Coumarins[40]

Contribute mild anticoagulant activity; relevant to the plant's caution around blood-thinning medication.

Coumarins

Pharmacological Actions

Diuretic[8, 13, 28, 30, 42]

Aquaretic diuretic; the classic irrigation-therapy action of restharrow root (Ononidis radix), used interchangeably for O. arvensis and O. spinosa.

Urinary antiseptic[15]

Aqueous root extract reduced adhesion of uropathogenic E. coli to bladder cells (anti-adhesive).

Anti-inflammatory[14, 16, 17, 39]

Inhibits IL-8 release via TLR4/LPS and cytosolic phospholipase A2alpha (restharrow root).

Antimicrobial[2, 13, 21, 41]
Vulnerary (wound healing)[16, 20]

Isoflavonoids from restharrow root promote wound healing in vivo.

Antioxidant[5, 6, 13, 21, 31, 34, 40]
Analgesic (pain relief)[18, 33]

Analgesic activity of Ononis extract in animals (congener O. spinosa).

Gastroprotective[19]

Protective against ethanol-induced gastric mucosal injury (congener O. spinosa).

Anticancer (preclinical)[5, 27]

Ononis isoflavones showed chemopreventive/antiproliferative activity against breast cancer cells (preclinical).

Antifungal[22]
Lipid-lowering[24, 35]
Antiplatelet / anticoagulant[26]
Anti-inflammatory[4, 14, 17, 22, 28, 33, 34, 40, 41]
Antioxidant[4, 6, 14, 16, 17, 22, 28, 29, 40, 41]
Antispasmodic[8, 14, 40, 41]

Antispasmodic (cramp easing)

Expectorant[14, 40, 41]
Lipid-lowering[5, 11, 13]
Anticancer (preclinical)[16, 18, 19, 20, 21, 35, 36, 37]
Neuroprotective / cognition support[23, 30, 31, 32]
Antidiabetic (blood-sugar lowering)[24, 25, 38]
Antimicrobial[17, 27]
Vulnerary (wound healing)[17, 39]

Traditional & Indicated Uses

Cancer (anticancer research)[5, 27]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Urinary support[8, 13, 15, 28, 30]Strong · 9/10

Aquaretic diuretic for irrigation therapy of the urinary tract.

Evidence: 9
Label: Urinary support
Urinary tract infection (UTI)[15]Traditional · 2/10

Anti-adhesive activity against uropathogenic E. coli.

Evidence: 2
Label: Urinary tract infection (UTI)
Kidney support[8, 13]Good · 7/10

inferred from diuretic / urinary 'gravel' traditional use

Evidence: 7
Label: Kidney support
Swelling / fluid retention[13]Good · 7/10

inferred from diuretic (aquaretic) action

Evidence: 7
Label: Swelling / fluid retention
Infection (general)[2]Traditional · 2/10

inferred from antimicrobial action

Evidence: 2
Label: Infection (general)
Wounds[16]Traditional · 2/10

Isoflavonoid wound-healing agents from restharrow root.

Evidence: 2
Label: Wounds
Skin irritation[8, 17]Traditional · 2/10

inferred from anti-inflammatory and traditional skin/eczema use

Evidence: 2
Label: Skin irritation
Inflammation (general)[14, 17]Traditional · 2/10
Evidence: 2
Label: Inflammation (general)
Pain (general)[18]Traditional · 2/10

inferred from analgesic action

Evidence: 2
Label: Pain (general)
Cardiovascular / heart health[24, 26, 35]Traditional · 2/10

Ononis isoflavonoids (maackiain, ononin) showed anti-adipogenic activity via PPAR-gamma inhibition (preclinical).

Evidence: 2
Label: Cardiovascular / heart health
Arthritis / joint pain[14, 34, 40, 41]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Arthritis / joint pain
Bronchitis[14, 40, 41]Moderate · 5/10

inferred from expectorant action

Evidence: 5
Label: Bronchitis
Cardiovascular / heart health[2, 10, 13, 14, 16, 33, 40, 41]Strong · 9/10
Evidence: 9
Label: Cardiovascular / heart health
Cough[14, 40, 41]Moderate · 5/10

inferred from expectorant action

Evidence: 5
Label: Cough
Inflammation (general)[14, 28, 40, 41]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Inflammation (general)
Menstrual cramps[8, 14, 40, 41]Moderate · 5/10
Evidence: 5
Label: Menstrual cramps
Muscle spasm[8, 14, 40, 41]Moderate · 5/10

inferred from antispasmodic action

Evidence: 5
Label: Muscle spasm
Respiratory support[14, 40, 41]Moderate · 5/10

inferred from expectorant action

Evidence: 5
Label: Respiratory support
Skin irritation[7, 14, 40, 41]Moderate · 5/10

inferred from anti-inflammatory action

Evidence: 5
Label: Skin irritation
Menopause[1, 5, 11, 12, 15]Strong · 9/10
Evidence: 9
Label: Menopause
Hot flashes[1, 5, 11, 12]Strong · 9/10
Evidence: 9
Label: Hot flashes
High cholesterol[5, 11, 13]Strong · 9/10
Evidence: 9
Label: High cholesterol
Cancer (anticancer research)[16, 18, 19, 20, 21, 35, 36, 37]Good · 7/10

inferred from anticancer action

Evidence: 7
Label: Cancer (anticancer research)
Blood sugar / diabetes support[24, 25, 38]Traditional · 2/10
Evidence: 2
Label: Blood sugar / diabetes support
Cognitive function[23, 30, 31, 32]Good · 8/10

inferred from neuroprotective action

Evidence: 8
Label: Cognitive function
Wounds[17, 39]Good · 7/10

inferred from vulnerary action

Evidence: 7
Label: Wounds

Safety, Cautions & Contraindications

Safety note[18]Warning

A safety signal exists in the genus: an Ononis spinosa root extract showed hepatotoxic effects at higher doses in animals (alongside analgesic activity). Avoid excessive or prolonged use, and use caution in liver disease.

Safety note[13]Caution

Used as an aquaretic for irrigation therapy of the urinary tract, restharrow should be taken with a generous fluid intake; it should NOT be used for 'flushing' when there is oedema due to impaired heart or kidney function (standard irrigation-therapy caution).

Safety note[1, 3]Caution

The root is rich in isoflavone phytoestrogens (formononetin); avoid medicinal doses in pregnancy and breastfeeding and use caution in hormone-sensitive conditions.

Safety note[14, 40, 41]Caution

Generally safe in normal dietary amounts. Isoflavones are phytoestrogens — exercise caution in oestrogen-receptor-positive breast cancer patients or those taking hormone therapies. May interact with warfarin (antiplatelet activity). Avoid in pregnancy and breastfeeding. Well tolerated in most adults.

Safety note[14, 40, 41, 42]Caution

Duke (2002) rates red clover as +++ and provides clinical evidence (score 2) for estrogenic activity — the plant is one of the richest plant sources of isoflavones (formononetin, biochanin A, daidzein, genistein). Clinical applications include menopausal symptom relief, osteoporosis prevention, and cardiovascular protection in peri-menopausal women. Dose: standardized extract providing 40–160 mg isoflavones daily. Duke cautions that due to strong estrogenic activity, red clover is not recommended in estrogen-dependent cancers (breast, uterine) or alongside hormone replacement therapy without medical supervision. Anti-coagulant coumarins are also present (Duke, 2002).

External Ids

Gbif: 2977171
Wikidata: Q164263
Gbif: 8324121
Wikidata: Q156635

Synonyms

Ononis hircina, Ononis arvensis subsp. arvensis

Not documented

Botanical Description

A tough, deep-rooted perennial herb or low subshrub of the pea family, 30-80 cm tall, sometimes bearing soft spines. It has a very long, woody, tenacious taproot - so strong it was said to stop (arrest) the harrow, giving 'rest-harrow' its name. The stems are hairy and sticky, often reddish, and clothed in small trifoliolate (clover-like) leaves with toothed leaflets. The flowers are typical pea flowers, pink to purplish-pink (occasionally white), borne singly or in pairs in the leaf axils. Field restharrow (O. arvensis) is generally less spiny than its close relative spiny restharrow (O. spinosa).[8, 10]

Height: 30-80 cm
Habit: Deep-rooted perennial herb or low subshrub, sometimes softly spiny
Leaves: Trifoliolate (clover-like), with finely toothed leaflets; stems hairy and glandular-sticky
Flowers: Pea-type, pink to purplish-pink (rarely white), solitary or paired in the leaf axils
Stem: Erect to ascending, hairy and sticky, often reddish; less spiny than O. spinosa
Root: Very long, woody, tenacious taproot (the medicinal Ononidis radix)
Fruit: A small, hairy, few-seeded pea pod
Flowering Period: June-September

Short-lived perennial herb with trifoliate leaves, each leaflet oval and often marked with a pale chevron, arising from a spreading, slightly hairy stem. Dense, rounded, pink to magenta flower heads are borne at the stem tips.[40]

Height: 20-60 cm
Habit: Short-lived perennial herb, spreading via a branching taproot
Leaves: Trifoliate, each leaflet oval with a pale chevron marking, slightly hairy
Flowers: Dense, rounded heads of small pink to magenta pea-like flowers
Stem: Slightly hairy, branching, spreading
Root: Branching taproot with nitrogen-fixing root nodules
Fruit: Small pod containing 1-2 seeds, enclosed within the dried flower head
Flowering Period: May-September

Habitat

Rough grassland, field margins, roadsides, dunes and dry, sandy or calcareous waste ground across Europe, western Asia and parts of North Africa. As a deep-rooted, nitrogen-fixing legume it colonises poor, disturbed soils and was historically a troublesome weed of arable fields (hence 'restharrow').[8]

Grows in meadows, pastures, roadsides and grassy waste ground; native to Europe, western Asia and North Africa and widely naturalised and cultivated as a forage crop elsewhere.[40]

Harvesting

The root (Ononidis radix) is the principal medicinal part, dug in autumn from the second year onward and dried; the aerial flowering parts are also gathered in summer. The long woody taproot is cleaned and cut before drying for decoctions and infusions.[8]

Parts: Root, Aerial parts
Season: Root in autumn; aerial parts in flower (summer)

The flowering heads are picked at full bloom in summer and dried quickly in a warm, shaded, airy place to preserve isoflavone content and colour.[40]

Parts: Flower, Leaf
Season: Summer, at full bloom

Traditional Uses

Restharrow root has a long place in European herbal medicine as a gentle aquaretic diuretic used for 'irrigation therapy' of the urinary tract - to increase urine flow in cystitis, urinary gravel and stones, and to flush the bladder. Field restharrow (Ononis arvensis) is used interchangeably with the officinal spiny restharrow (O. spinosa, Ononidis radix). The root and flowering herb have also been used as a mild anti-inflammatory, for skin complaints and eczema, for rheumatic conditions, and (as a decoction or gargle) for the mouth and throat. The isoflavone-rich root is a folk remedy in central and eastern European traditions.[8, 13]

Red clover flower has a long folk tradition as a blood-purifying and expectorant remedy for coughs and skin complaints, and more recently has become one of the most studied herbal sources of isoflavone phytoestrogens, researched for menopausal symptom relief and cardiovascular and bone support.[14, 40, 41]

Preparations

Decoction[8, 13]

The dried root simmered in water and taken as an aquaretic diuretic for irrigation of the urinary tract; the classic restharrow preparation.

Infusion[8]

The flowering aerial parts infused as a milder diuretic and anti-inflammatory tea.

Gargle / wash[8]

A root decoction used traditionally as a mouth/throat gargle and as a wash for skin complaints.

Infusion (flower)[40]

Dried flower heads infused in hot water as a traditional tea for coughs and as a general tonic.

Standardized isoflavone extract[14]

Standardized isoflavone extract in tablet form, the form used in most menopause-related clinical research.

References

REF-2741, REF-2742, REF-2743, REF-2744, REF-2745, REF-2746, REF-2747, REF-2748, REF-2749, REF-2750, REF-2751, REF-2752, REF-2753, REF-2754, REF-2755, REF-2756, REF-2757, REF-2758, REF-2759, REF-2760, REF-3015, REF-3016, REF-3017, REF-3018, REF-3019, REF-3020, REF-3021, REF-3022, REF-3023, REF-3024, REF-3025, REF-3026, REF-3027, REF-3028, REF-3029, REF-3030, REF-3031, REF-3032, REF-3033, REF-3034, REF-3035, REF-3036
REF-1104, REF-1105, REF-1106, REF-1107, REF-1108, REF-1109, REF-1110, REF-1111, REF-1112, REF-1113, REF-2344, REF-2345, REF-2346, REF-0013, REF-2347, REF-2889, REF-2890, REF-2891, REF-2892, REF-2893, REF-2894, REF-2895, REF-2896, REF-2897, REF-2898, REF-2899, REF-2900, REF-2923, REF-2924, REF-2925, REF-2926, REF-2927, REF-2928, REF-2929, REF-2930, REF-2931, REF-2932, REF-2933, REF-2934

Drug Class Interactions

Safety note[8, 13]Caution
Drug Class: diuretics
Mechanism: Restharrow is an aquaretic diuretic; taken with pharmaceutical diuretics it may add to fluid and electrolyte loss.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10
Safety note[1, 3]Caution
Drug Class: hormonal-therapies
Mechanism: The root is rich in the isoflavone phytoestrogen formononetin; it could theoretically interact with hormonal contraceptives, hormone replacement or hormone-sensitive conditions.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10
Safety note[43, 44]Caution
Drug Class: hormonal-therapies
Mechanism: Red clover is rich in isoflavones that act like weak oestrogens; its safety alongside hormone medicines (such as the contraceptive pill, HRT, or breast-cancer hormone treatments like tamoxifen) or in hormone-sensitive conditions is not established, so combined use warrants caution and medical advice.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Pairings

Classic urinary irrigation-therapy pairing: both are aquaretic diuretics used to increase urine flow in cystitis and urinary gravel.[13]

Partner Id: solidago-virgaurea
Type: synergy
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Both are traditional diuretic 'flushing' herbs for irrigation therapy of the urinary tract.[13]

Partner Id: betula-pendula
Type: synergy
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Both are Fabaceae rich in the isoflavone phytoestrogen formononetin; combined use adds to phytoestrogen exposure - use caution in hormone-sensitive conditions.[1]

Partner Id: trifolium-pratense
Type: caution
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10

Not documented

Lookalikes Review

[8]

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-10
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

Dosage

Not documented

Standardized extract[14]

Clinical research commonly uses around 40-80 mg isoflavones daily. Educational reference only, not a prescription.

References & Sources

  1. Gampe, N. and Darcsi, A. and Nagyne Nedves, A. and Boldizsar, I. and Kursinszki, L. and Beni, S (2019) 'Phytochemical analysis of Ononis arvensis L. by liquid chromatography coupled with mass spectrometry', Journal of Mass Spectrometry, 54(2), pp. 121-133. doi:10.1002/jms.4308 Preclinical
    https://doi.org/10.1002/jms.4308
  2. Denes, T. and Bartha, S.G. and Kerenyi, M. and Varga, E. and Balazs, V.L. and Csepregi, R. and Papp, N (2017) 'Histological and antimicrobial study of Ononis arvensis L', Acta Biologica Hungarica, 68(3), pp. 321-333. doi:10.1556/018.68.2017.3.9 Preclinical
    https://doi.org/10.1556/018.68.2017.3.9
  3. Gampe, N. and Nagy, E. and Kursinszki, L. and Beni, S (2021) 'Quantitative determination of isoflavonoids in Ononis species by UPLC-UV-DAD', Phytochemical Analysis, 32(4), pp. 474-481. doi:10.1002/pca.2995 Preclinical
    https://doi.org/10.1002/pca.2995
  4. Gampe, N. and Szakacs, Z. and Darcsi, A. and Boldizsar, I. and Szoke, E. and Kuzovkina, I. and Kursinszki, L. and Beni, S (2021) 'Qualitative and Quantitative Phytochemical Analysis of Ononis arvensis Hairy Root Cultures', Frontiers in Plant Science, 11, pp. 622585. doi:10.3389/fpls.2020.622585 Preclinical
    https://doi.org/10.3389/fpls.2020.622585
  5. Pazdziora, W. and Grabowska, K. and Zagrodzki, P. and Pasko, P. and Prochownik, E. and Podolak, I. and Galanty, A (2025) 'Quantitative Analysis of Isoflavones from Ononis Species and Their Chemopreventive Potential on Breast Cancer Cells', Molecules, 30(11), pp. 2379. doi:10.3390/molecules30112379 Preclinical
    https://doi.org/10.3390/molecules30112379
  6. Spilkova, J. and Bednar, P. and Stroblikova, R (2001) 'Capillary electrophoretic analysis of hydroxycinnamic acids from Ononis arvensis L', Die Pharmazie, 56(5), pp. 424-425. Preclinical
    https://scholar.google.com/scholar?q=Capillary%20electrophoretic%20analysis%20of%20hydroxycinnamic%20acids%20from%20Ononis%20arvensis%20L.
  7. Spilkova, J. and Hubik, J (1982) 'Pharmacognosy study of Ononis arvensis L. II. Flavonoids and onocerin in the drug', Ceskoslovenska Farmacie, 31(1), pp. 24-26. Preclinical
    https://scholar.google.com/scholar?q=Pharmacognosy%20study%20of%20Ononis%20arvensis%20L.%20II.%20Flavonoids%20and%20onocerin%20in%20the%20drug
  8. Rezacova, A. and Spilkova, J. and Hubik, J (1978) 'A pharmacognostic study of the species Ononis arvensis L', Ceskoslovenska Farmacie, 27(10), pp. 452-455. Traditional / reference
    https://scholar.google.com/scholar?q=A%20pharmacognostic%20study%20of%20the%20species%20Ononis%20arvensis%20L.
  9. Felsberg, A.A. and Rosentsveig, P.E (1965) 'A comparative phytochemical study of the roots of Ononis arvensis L. and Ononis spinosa L', Aptechnoe Delo, 14(6), pp. 26-32. Preclinical
    https://scholar.google.com/scholar?q=A%20comparative%20phytochemical%20study%20of%20the%20roots%20of%20Ononis%20arvensis%20L.%20and%20Ononis%20spinosa%20L.
  10. Sichinava, M.B. and Mchelidze, K.Z. and Churadze, M.V. and Alaniia, M.D. and Aneli, D.N (2014) 'Chemical composition and microstructural peculiarities of overground and underground vegetative organs of field restharrow (Ononis arvensis L.)', Georgian Medical News, (231), pp. 88-94. Preclinical
    https://scholar.google.com/scholar?q=Chemical%20composition%20and%20microstructural%20peculiarities%20of%20overground%20and%20underground%20vegetative%20organs%20of%20field%20restharrow%20%28Ononis%20arvensis%20L.%29
  11. Dedio, I. and Kozlowski, J (1977) 'Comparative morphological and phytochemical studies of Ononis spinosa L. and Ononis arvensis L. I. Biometric and chromatographic studies of methanolic extracts', Acta Poloniae Pharmaceutica, 34(1), pp. 97-102. Preclinical
    https://scholar.google.com/scholar?q=Comparative%20morphological%20and%20phytochemical%20studies%20of%20Ononis%20spinosa%20L.%20and%20Ononis%20arvensis%20L.%20I.%20Biometric%20and%20chromatographic%20studies%20of%20methanolic%20extracts
  12. Felsberg, A.A. and Rozentsveig, P.E (1965) 'Photochemical examination of Ononis arvensis. I', Aptechnoe Delo, 14(3), pp. 25-27. Preclinical
    https://scholar.google.com/scholar?q=Photochemical%20examination%20of%20Ononis%20arvensis.%20I
  13. Nechita, V. and Tarau, A. and Suster, A. and Nechita, M. and Toiu, A. and Benedec, D. and Hanganu, D. and Siserman, C. and Drugan, C. and Oniga, I (2026) 'Phytochemical Constituents and Biological Activities of Ononis spinosa: A Comprehensive Review', Plants (Basel), 15(9), pp. 1409. doi:10.3390/plants15091409 Meta-analysis / review
    https://doi.org/10.3390/plants15091409
  14. Spiegler, V. and Gierlikowska, B. and Saenger, T. and Addotey, J.N. and Sendker, J. and Jose, J. and Kiss, A.K. and Hensel, A (2020) 'Root Extracts From Ononis spinosa Inhibit IL-8 Release Via Interactions With Toll-Like Receptor 4 and Lipopolysaccharide', Frontiers in Pharmacology, 11, pp. 889. doi:10.3389/fphar.2020.00889 Preclinical
    https://doi.org/10.3389/fphar.2020.00889
  15. Deipenbrock, M. and Sendker, J. and Hensel, A (2020) 'Aqueous Root Extract from Ononis spinosa Exerts Anti-adhesive Activity against Uropathogenic Escherichia coli', Planta Medica, 86(4), pp. 247-254. doi:10.1055/a-1089-8645 Preclinical
    https://doi.org/10.1055/a-1089-8645
  16. Ergene Oz, B. and Saltan Iscan, G. and Kupeli Akkol, E. and Suntar, I. and Bahadir Acikara, O (2017) 'Isoflavonoids as wound healing agents from Ononidis Radix', Journal of Ethnopharmacology, 211, pp. 384-393. doi:10.1016/j.jep.2017.09.029 Preclinical
    https://doi.org/10.1016/j.jep.2017.09.029
  17. Arnold, E. and Benz, T. and Zapp, C. and Wink, M (2015) 'Inhibition of Cytosolic Phospholipase A2alpha (cPLA2alpha) by Medicinal Plants in Relation to Their Phenolic Content', Molecules, 20(8), pp. 15033-15048. doi:10.3390/molecules200815033 Preclinical
    https://doi.org/10.3390/molecules200815033
  18. Yilmaz, B.S. and Ozbek, H. and Citoglu, G.S. and Ugras, S. and Bayram, I. and Erdogan, E (2006) 'Analgesic and hepatotoxic effects of Ononis spinosa L', Phytotherapy Research, 20(6), pp. 500-503. doi:10.1002/ptr.1891 Preclinical
    https://doi.org/10.1002/ptr.1891
  19. Manal Ahmad, A. and Yasser Ibrahim, K. and Manal Mohammad, A (2021) 'Efficacy of extract from Ononis spinosa L. on ethanol-induced gastric mucosal injury in rats', Journal of Traditional Chinese Medicine, 41(2), pp. 270-275. Preclinical
    https://scholar.google.com/scholar?q=Efficacy%20of%20extract%20from%20Ononis%20spinosa%20L.%20on%20ethanol-induced%20gastric%20mucosal%20injury%20in%20rats
  20. Addotey, J.N. and Lengers, I. and Jose, J. and Gampe, N. and Beni, S. and Petereit, F. and Hensel, A (2018) 'Isoflavonoids with inhibiting effects on human hyaluronidase-1 and norneolignan clitorienolactone B from Ononis spinosa L. root extract', Fitoterapia, 130, pp. 169-174. doi:10.1016/j.fitote.2018.08.013 Preclinical
    https://doi.org/10.1016/j.fitote.2018.08.013
  21. Stojković, D. and Drakulić, D. and Gašić, U. and Zengin, G. and Stevanović, M. and Rajčević, N. and Sokóvić, M (2020) 'Ononis spinosa L., an edible and medicinal plant: UHPLC-LTQ-Orbitrap/MS chemical profiling and biological activities of the herbal extract', Food & Function. doi:10.1039/d0fo01595d Preclinical
    https://doi.org/10.1039/d0fo01595d
  22. Stojković, D. and Días, M.I. and Drakulić, D. and Barros, L. and Stevanović, M. and Ferreira, I.C. and Sokóvić, M (2020) 'Methanolic Extract of the Herb Ononis spinosa L. Is an Antifungal Agent with no Cytotoxicity to Primary Human Cells', Pharmaceuticals. doi:10.3390/ph13040078 Preclinical
    https://doi.org/10.3390/ph13040078
  23. Kırmızıgül, S. and Gören, N. and Yang, S. and Cordell, G.A. and Bozok-Johansson, C (1997) 'Spinonin, a Novel Glycoside from Ononis spinosa subsp. leiosperma', Journal of Natural Products. doi:10.1021/np9605652 Preclinical
    https://doi.org/10.1021/np9605652
  24. Mladenova, S.G. and Savova, M.S. and Marchev, A.S. and Ferrante, C. and Orlando, G. and Wabitsch, M. and Georgiev, M.I (2022) 'Anti-adipogenic activity of maackiain and ononin is mediated via inhibition of PPARγ in human adipocytes', Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2022.112908 Preclinical
    https://doi.org/10.1016/j.biopha.2022.112908
  25. Лужанин, В.Г. and Whaley, A.K. and Ponkratova, A.O. and Grishukova, E.A. and Suloev, I.S. and Смирнов, С.Н. and Serebryakov, E.B (2021) 'Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L', Drug development & registration. doi:10.33380/2305-2066-2021-10-1-83-89 Preclinical
    https://doi.org/10.33380/2305-2066-2021-10-1-83-89
  26. Bogoutdinova, A. and Whaley, A.K. and Ponkratova, A.O. and Orlova, A. and Goncharov, M.Y. and Shpakova, V. and Farmanova, N.T. and Nurullaeva, D.K. and Sharipov, A. and Gambaryan, S. and Повыдыш, М.Н (2021) 'Isolation of formononetin-7-O-β-D-glucopyranoside from the grass of Ononis arvensis L. and the assessment of its effect on induced platelet activation', Drug development & registration. doi:10.33380/2305-2066-2021-10-4(1)-14-19 Preclinical
    https://doi.org/10.33380/2305-2066-2021-10-4(1)-14-19
  27. Paździora, W. and Grabowska, K. and Paśko, P. and Prochownik, E. and Podolak, I. and Galanty, A (2026) 'Multifaceted Evaluation of Isoflavone-Rich Fabaceae Species in Prostate Cancer In Vitro Models', Applied Sciences. doi:10.3390/app16136289 Preclinical
    https://doi.org/10.3390/app16136289
  28. Gallo, G. and Cicione, A. and Nacchia, A. and Lombardo, R. and Riolo, S. and Guercio, A. and Fiasconaro, D. and Nunzio, C.D (2026) 'A randomized controlled trial comparing alpha-blocker (tamsulosin) and a phyto-complex (Solidago virga-aurea, Phyllantus niruri, Epilobium angustifolium, Peumus boldus and Ononis spinosa) in the treatment of ureteral stent-related symptoms', Urologia Journal. doi:10.1177/03915603261454171 Randomized trial
    https://doi.org/10.1177/03915603261454171
  29. Ismailov, E. and Рогожникова, Е. and Марданлы, С.Г. and Мизина, П. and Kalinina, T.S (2024) 'COMPARATIVE STUDY OF SETTINGS FROM WILD SPECIES OF STEELWORM', Problems of Biological Medical and Pharmaceutical Chemistry. doi:10.29296/25877313-2024-12-02 Preclinical
    https://doi.org/10.29296/25877313-2024-12-02
  30. Mauro, E.D. and Saldutto, P. and Rocca, R.L. and Sangiorgi, G. and Patelli, G. and Barone, B. and Verratti, V. and Castellucci, R. and Napolitano, L. and Iacono, F. and Altieri, V (2024) 'Efficacy and Safety of Boldine Combined with Phyllanthus niruri and Ononis spinosa in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Single-Center, Retrospective Cohort Study', Medicina. doi:10.3390/medicina60091455 Clinical study
    https://doi.org/10.3390/medicina60091455
  31. DÉNES, T (2022) 'PHYTOCHEMICAL INVESTIGATION AND ANTIOXIDANT POTENTIAL OF ONONIS ARVENSIS L', FARMACIA. doi:10.31925/farmacia.2022.3.20 Preclinical
    https://doi.org/10.31925/farmacia.2022.3.20
  32. Zarga, M.H.A. and Al‐Jaber, H.I. and Al‐Qudah, M.A. and Al-Aboudi, A.M (2021) 'A new cyclic polyketide and other constituents from Ononis spinosa growing wildly in Jordan and their antioxidant activity', Journal of Asian Natural Products Research. doi:10.1080/10286020.2021.1914597 Preclinical
    https://doi.org/10.1080/10286020.2021.1914597
  33. Abbas, M.A. and Jaffal, S.M (2019) 'ANTINOCICEPTIVE ACTION OF ONONIS SPINOSA LEAF EXTRACT IN MOUSE PAIN MODELS', Acta Poloniae Pharmaceutica - Drug Research. doi:10.32383/appdr/99291 Preclinical
    https://doi.org/10.32383/appdr/99291
  34. (2009) 'Radical scavenger and Antioxidant activities of extracts and fractions from Bulgarian Ononis spinosa L. and GC-MS analysis of Ethanol extract', The Internet Journal of Alternative Medicine. doi:10.5580/121d Preclinical
    https://doi.org/10.5580/121d
  35. Davitavyan, N. and Е.Б., Н. and Pogulyay, Y. and Khochava, M. and Мизина, П. and Адамов, Г (2024) 'STUDYING THE HYPOLYPIDEMIC ACTIVITY OF FLAVONOIDS AND ISOFLAVONOIDS OF THE ONONIS ARVENSIS L. METHODS BY IN SILICO', Problems of Biological Medical and Pharmaceutical Chemistry. doi:10.29296/25877313-2024-05-01 Preclinical
    https://doi.org/10.29296/25877313-2024-05-01
  36. Gampe, N. and Dávid, D.N. and Takács‐Novák, K. and Backlund, A. and Béni, S (2022) 'In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system', PLoS ONE. doi:10.1371/journal.pone.0265639 Preclinical
    https://doi.org/10.1371/journal.pone.0265639
  37. Pauli, G.F (2000) 'Comprehensive Spectroscopic Investigation of α-Onocerin', Planta Medica. doi:10.1055/s-2000-14895 Preclinical
    https://doi.org/10.1055/s-2000-14895
  38. Köster, J. and Strack, D. and Barz, W (1983) 'High Performance Liquid Chromatographic Separation of Isoflavones and Structural Elucidation of Isoflavone 7-O-glucoside 6″-malonates from Cicer arietinum', Planta Medica. doi:10.1055/s-2007-969907 Preclinical
    https://doi.org/10.1055/s-2007-969907
  39. Spiegler, V. and Michalak, B. and Addotey, J.N. and Saenger, T. and Jose, J. and Kiss, A.K. and Hensel, A (2019) 'Root extracts from Ononis spinosa exert anti-inflammatory activity in vitro on IL-8 and TNF-α release by inhibition of TLR-4 receptor', Planta Medica. doi:10.1055/s-0039-3399691 Preclinical
    https://doi.org/10.1055/s-0039-3399691
  40. Çoban, T. and Çitoğlu, G.S. and Yılmaz, B.S. and İşcan, M (2003) 'Antioxidant Activities of Plants Used in Traditional Medicine in Turkey', Pharmaceutical Biology. doi:10.1080/13880200390501974 Preclinical
    https://doi.org/10.1080/13880200390501974
  41. Obiștioiu, D. and Cocan, I. and Tîrziu, E. and Herman, V. and Negrea, M. and Ban-Cucerzan, A. and Neacşu, A. and Cozma, A. and Nichita, I. and Hulea, A. and Radulov, I. and Alexa, E (2021) 'Phytochemical Profile and Microbiological Activity of Some Plants Belonging to the Fabaceae Family', Antibiotics. doi:10.3390/antibiotics10060662 Preclinical
    https://doi.org/10.3390/antibiotics10060662
  42. Orlando, G. and Chiavaroli, A. and Ferrante, C. and Recinella, L. and Leone, S. and Brunetti, L. and Simone, S.C.D. and Menghini, L. and Petrucci, M. and Zengin, G. and Cesaroni, F. and Pontarelli, G. and Cindolo, L. and Neri, F (2021) 'Protective effects induced by the food supplement Fluxonorm® in the lower urinary tract', PubMed. doi:10.26355/eurrev_202104_25562 Preclinical
    https://doi.org/10.26355/eurrev_202104_25562
  1. Kanadys, W., Baranska, A., Blaszczuk, A., Polz-Dacewicz, M. and others (2021) 'Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Nutrients, 13(4), pp. 1258. doi:10.3390/nu13041258 Meta-analysis / review
    https://doi.org/10.3390/nu13041258
  2. Kanadys, W., Baranska, A., Jedrych, M., Religioni, U. and others (2019) 'Effects of red clover (Trifolium pratense) isoflavones on the lipid profile of perimenopausal and postmenopausal women-A systematic review and meta-analysis', Maturitas, 132, pp. 7-16. doi:10.1016/j.maturitas.2019.11.001 Meta-analysis / review
    https://doi.org/10.1016/j.maturitas.2019.11.001
  3. Yokoyama, S.I., Kodera, M., Hirai, A., Nakada, M. and others (2020) 'Red Clover (Trifolium pratense L.) Sprout Prevents Metabolic Syndrome', Journal of Nutritional Science and Vitaminology, 66(1), pp. 48-53. doi:10.3177/jnsv.66.48 Preclinical
    https://doi.org/10.3177/jnsv.66.48
  4. Gosciniak, A., Szulc, P., Zielewicz, W., Walkowiak, J. and others (2023) 'Multidirectional Effects of Red Clover (Trifolium pratense L.) in Support of Menopause Therapy', Molecules, 28(13), pp. 5178. doi:10.3390/molecules28135178 Meta-analysis / review
    https://doi.org/10.3390/molecules28135178
  5. Booth, N.L., Piersen, C.E., Banuvar, S., Geller, S.E. and others (2006) 'Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review', Menopause, 13(2), pp. 251-264. doi:10.1097/01.gme.0000198297.40269.f7 Meta-analysis / review
    https://doi.org/10.1097/01.gme.0000198297.40269.f7
  6. Oza, M.J. and Kulkarni, Y.A (2020) 'Trifolium pratense (Red Clover) Improves SIRT1 Expression and Glycogen Content in High Fat Diet-Streptozotocin Induced Type 2 Diabetes in Rats', Chemistry & Biodiversity, 17(4), pp. e2000019. doi:10.1002/cbdv.202000019 Preclinical
    https://doi.org/10.1002/cbdv.202000019
  7. Circosta, C., De Pasquale, R., Palumbo, D.R., Samperi, S. and others (2006) 'Effects of isoflavones from red clover (Trifolium pratense) on skin changes induced by ovariectomy in rats', Phytotherapy Research, 20(12), pp. 1096-1099. doi:10.1002/ptr.2017 Preclinical
    https://doi.org/10.1002/ptr.2017
  8. Brandli, A., Simpson, J.S. and Ventura, S (2010) 'Isoflavones isolated from red clover (Trifolium pratense) inhibit smooth muscle contraction of the isolated rat prostate gland', Phytomedicine, 17(11), pp. 895-901. doi:10.1016/j.phymed.2010.05.006 Preclinical
    https://doi.org/10.1016/j.phymed.2010.05.006
  9. Burdette, J.E., Liu, J., Lantvit, D., Lim, E. and others (2002) 'Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats', The Journal of Nutrition, 132(1), pp. 27-30. doi:10.1093/jn/132.1.27 Preclinical
    https://doi.org/10.1093/jn/132.1.27
  10. Jiang, Y.B. and Yang, Y.R (2016) 'Trifolium pratense isoflavones improve pulmonary vascular remodelling in broiler chickens', Journal of Animal Physiology and Animal Nutrition, 100(6), pp. 1159-1168. doi:10.1111/jpn.12424 Preclinical
    https://doi.org/10.1111/jpn.12424
  11. Yigit, E. and Unsal, S (2024) 'Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial', Climacteric, 27(6), pp. 548-554. doi:10.1080/13697137.2024.2393121 Randomized trial
    https://doi.org/10.1080/13697137.2024.2393121
  12. Lethaby, A.E., Brown, J., Marjoribanks, J., Kronenberg, F., Roberts, H. and Eden, J (2007) 'Phytoestrogens for vasomotor menopausal symptoms', Cochrane Database of Systematic Reviews, (4), pp. CD001395. doi:10.1002/14651858.CD001395.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD001395.pub3
  13. Geller, S.E. and Studee, L (2006) 'Soy and red clover for mid-life and aging', Climacteric, 9(4), pp. 245-263. doi:10.1080/13697130600736934 Meta-analysis / review
    https://doi.org/10.1080/13697130600736934
  14. Atkinson, C. et al (2004) 'The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial', 79(2), pp. 326--333. doi:10.1093/ajcn/79.2.326 Randomized trial
    https://doi.org/10.1093/ajcn/79.2.326
  15. Quah, Y., Yi-Le, J.C., Park, N.H., Lee, Y.Y., Lee, E.B., Jang, S.H., Kim, M.J., Rhee, M.H., Lee, S.J. and Park, S.C (2022) 'Serum biomarker-based osteoporosis risk prediction and the systemic effects of Trifolium pratense ethanolic extract in a postmenopausal model', Chinese Medicine, 17(1), pp. 70. doi:10.1186/s13020-022-00622-7 Preclinical
    https://doi.org/10.1186/s13020-022-00622-7
  16. Mohsen, A. and Fatemeh, K. and Leila, N. and Mona, P. and Mohammad, Z. and Mozafar, K (2021) 'Pharmacological and therapeutic properties of the Red Clover (Trifolium pratense L.): an overview of the new finding', J Tradit Chin Med, 41(4), pp. 642-649. doi:10.19852/j.cnki.jtcm.20210324.001 Meta-analysis / review
    https://doi.org/10.19852/j.cnki.jtcm.20210324.001
  17. Antonescu Mintas, A.I. and Miere Groza, F. and Fritea, L. and Ganea, M. and Zdrinca, M. and Dobjanschi, L. and Antonescu, A. and Vicas, S.I. and Bodog, F. and Sindhu, R.K. and Cavalu, S (2021) 'Perspectives on the Combined Effects of Trifolium pratense and Ocimum basilicum Extracts in Terms of Phytochemical Profile and Pharmacological Effects', Plants (Basel), 10(7). doi:10.3390/plants10071390 Meta-analysis / review
    https://doi.org/10.3390/plants10071390
  18. Tanrıverdi, G. and Abdulova, A. and Çölgeçen, H. and Atar, H. and Kaleci, B. and Ekiz-Yılmaz, T (2023) 'Investigation of apoptotic and antiproliferative effects of Turkish natural tetraploid Trifolium pratense L. extract on C6 glioblastoma cells via light and electron microscopy', Ultrastruct Pathol, 47(3), pp. 160-171. doi:10.1080/01913123.2023.2184893 Preclinical
    https://doi.org/10.1080/01913123.2023.2184893
  19. Zakłos-Szyda, M. and Budryn, G (2020) 'The Effects of Trifolium pratense L. Sprouts' Phenolic Compounds on Cell Growth and Migration of MDA-MB-231, MCF-7 and HUVEC Cells', Nutrients, 12(1). doi:10.3390/nu12010257 Preclinical
    https://doi.org/10.3390/nu12010257
  20. Khazayel, S. and Faraji, M.H. and Akbaribazm, M. and Khazaei, M. and Niromand, E. and Khazaei, M.R (2025) 'Synergistic inhibitory effects of Trifolium pratense L. extract and doxorubicin on 4T1 tumor-bearing mice are mediated via targeting the Wnt/beta-catenin pathway and reversal of epithelial-mesenchymal transition', Avicenna J Phytomed, 15(5), pp. 1546-1561. doi:10.22038/ajp.2025.25940 Preclinical
    https://doi.org/10.22038/ajp.2025.25940
  21. Shirani Asl, V. and Rafieemehr, H. and Tamaddon, G (2024) 'The impact of Trifolium pratense extract on apoptosis and autophagy in NALM-6 cells: implications for B-ALL intervention', Med Oncol, 41(11), pp. 257. doi:10.1007/s12032-024-02485-4 Preclinical
    https://doi.org/10.1007/s12032-024-02485-4
  22. Won, J.P. and Kim, E. and Hur, J. and Lee, H.G. and Lee, W.J. and Seo, H.G (2023) 'Red clover (Trifolium pratense L.) extract inhibits ferroptotic cell death by modulating cellular iron homeostasis', J Ethnopharmacol, 308, pp. 116267. doi:10.1016/j.jep.2023.116267 Preclinical
    https://doi.org/10.1016/j.jep.2023.116267
  23. Al-Shami, A.S. and Essawy, A.E. and Elkader, H.A.E.A (2023) 'Molecular mechanisms underlying the potential neuroprotective effects of Trifolium pratense and its phytoestrogen-isoflavones in neurodegenerative disorders', Phytother Res, 37(6), pp. 2693-2737. doi:10.1002/ptr.7870 Meta-analysis / review
    https://doi.org/10.1002/ptr.7870
  24. Zhang, H. and Zhao, J. and Shang, H. and Guo, Y. and Chen, S (2020) 'Extraction, purification, hypoglycemic and antioxidant activities of red clover (Trifolium pratense L.) polysaccharides', Int J Biol Macromol, 148, pp. 750-760. doi:10.1016/j.ijbiomac.2020.01.194 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2020.01.194
  25. Khazaei, A.H. and Bozorgi, A. and Ghanbari, E. and Bozorgi, M. and Khazaei, M (2025) 'Trifolium pratense-Derived Exosome Improved Serum Biochemical Parameters and Pancreatic Genes in STZ-Induced Diabetic Rats', Endocrinol Diabetes Metab, 8(5), pp. e70103. doi:10.1002/edm2.70103 Preclinical
    https://doi.org/10.1002/edm2.70103
  26. Hitzman, R. and Malca-Garcia, G.R. and Howell, C. and Park, H.Y. and Friesen, J.B. and Dong, H. and Dunlap, T. and McAlpine, J.B. and Vollmer, G. and Bosland, M.C. and Nikolić, D. and Lankin, D.C. and Chen, S.N. and Bolton, J.L. and Pauli, G.F. and Dietz, B.M (2023) 'DESIGNER fraction concept unmasks minor bioactive constituents in red clover (Trifolium pratense L.)', Phytochemistry, 214, pp. 113789. doi:10.1016/j.phytochem.2023.113789 Preclinical
    https://doi.org/10.1016/j.phytochem.2023.113789
  27. Lien, Y.Y. and Shyur, L.F. and Cheng, Y.B. and Chang, M.T. and Chang, C.T. and Chen, Y.H. and Lai, G.H. and Liao, H.Y. and Cheng, M.C (2024) 'Trifolium pratense as a novel phytogenic supplement, is an anticoccidial agent in chickens', Poult Sci, 103(10), pp. 104064. doi:10.1016/j.psj.2024.104064 Preclinical
    https://doi.org/10.1016/j.psj.2024.104064
  28. Lee, S.G. and Brownmiller, C. and Lee, S. and Kang, H.W (2020) 'Anti-Inflammatory and Antioxidant Effects of Anthocyanins of Trifolium pratense (Red Clover) in Lipopolysaccharide-Stimulated RAW-267.4 Macrophages', Nutrients, 12(4), pp. 1089-1089. doi:10.3390/nu12041089 Preclinical
    https://doi.org/10.3390/nu12041089
  29. Akbaribazm, M. and Khazaei, M.R. and Khazaei, M.R. and Khazaei, M. and Khazaei, M (2020) 'Phytochemicals and antioxidant activity of alcoholic/hydroalcoholic extract of Trifolium pratense', Chinese Herbal Medicines, 12(3), pp. 326-335. doi:10.1016/j.chmed.2020.02.002 Preclinical
    https://doi.org/10.1016/j.chmed.2020.02.002
  30. Fu, X. and Qin, T. and Yu, J. and Jiao, J. and Ma, Z. and Fu, Q. and Deng, X. and Ma, S (2019) 'Formononetin Ameliorates Cognitive Disorder via PGC-1α Pathway in Neuroinflammation Conditions in High-Fat Diet-Induced Mice', CNS & Neurological Disorders - Drug Targets, 18(7), pp. 566-577. doi:10.2174/1871527318666190807160137 Preclinical
    https://doi.org/10.2174/1871527318666190807160137
  31. Singh, L. and Kaur, H. and Arya, G.C. and Bhatti, R (2023) 'Neuroprotective potential of formononetin, a naturally occurring isoflavone phytoestrogen', Chemical Biology & Drug Design, 103(1), pp. e14353-e14353. doi:10.1111/cbdd.14353 Meta-analysis / review
    https://doi.org/10.1111/cbdd.14353
  32. Tan, J.W. and Kim, M (2016) 'Neuroprotective Effects of Biochanin A against β-Amyloid-Induced Neurotoxicity in PC12 Cells via a Mitochondrial-Dependent Apoptosis Pathway', Molecules, 21(5), pp. 548-548. doi:10.3390/molecules21050548 Preclinical
    https://doi.org/10.3390/molecules21050548
  33. Bai, Y. and Li, Z. and Liu, W. and Gao, D. and Liu, M. and Zhang, P (2019) 'Biochanin A attenuates myocardial ischemia/reperfusion injury through the TLR4/NF-κB/NLRP3 signaling pathway', Acta Cirúrgica Brasileira, 34(11), pp. e201901104-e201901104. doi:10.1590/s0102-865020190110000004 Preclinical
    https://doi.org/10.1590/s0102-865020190110000004
  34. Félix, F.B. and Vago, J.P. and Fernandes, D.D.O. and Martins, D.G. and Zaidan, I. and Gonçalves, W.A. and Costa, W.C. and Araújo, J.M.D. and Queiroz‐Junior, C.M. and Campolina-Silva, G.H. and Soriani, F.M. and Sousa, L.P. and Grespan, R. and Teixeira, M.M. and Pinho, V (2021) 'Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism', Frontiers in Pharmacology, 12, pp. 662308-662308. doi:10.3389/fphar.2021.662308 Preclinical
    https://doi.org/10.3389/fphar.2021.662308
  35. Akbaribazm, M. and Khazaei, M.R. and Khazaei, M.R. and Khazaei, M. and Khazaei, M (2020) 'Trifolium pratense L. (red clover) extract and doxorubicin synergistically inhibits proliferation of 4T1 breast cancer in tumor‐bearing BALB/c mice through modulation of apoptosis and increase antioxidant and anti‐inflammatory related pathways', Food Science & Nutrition, 8(8), pp. 4276-4290. doi:10.1002/fsn3.1724 Preclinical
    https://doi.org/10.1002/fsn3.1724
  36. Akbaribazm, M. and Khazaei, M.R. and Khazaei, M.R. and Khazaei, F. and Khazaei, M. and Khazaei, M (2020) 'Doxorubicin and Trifolium pratense L. (Red clover) extract synergistically inhibits brain and lung metastases in 4T1 tumor‐bearing BALB/c mice', Food Science & Nutrition, 8(10), pp. 5557-5570. doi:10.1002/fsn3.1820 Preclinical
    https://doi.org/10.1002/fsn3.1820
  37. Khazaei, M. and Pazhouhi, M (2018) 'Antiproliferative Effect of Trifolium Pratens L. Extract in Human Breast Cancer Cells', Nutrition and Cancer, 71(1), pp. 128-140. doi:10.1080/01635581.2018.1521443 Preclinical
    https://doi.org/10.1080/01635581.2018.1521443
  38. Pazhouhi, M. and Khazaei, M (2018) 'Protective effect of hydroalcoholic extracts of Trifolium pratense L. on pancreatic β cell line (RIN-5F) against cytotoxicty of streptozotocin', Research in Pharmaceutical Sciences, 13(4), pp. 324-324. doi:10.4103/1735-5362.235159 Preclinical
    https://doi.org/10.4103/1735-5362.235159
  39. Antonescu, I.A. and Antonescu, A. and Miere, F. and Fritea, L. and Teușdea, A.C. and Vicaș, L.G. and Vicaş, S.I. and Brihan, I. and Domuța, M. and Zdrîncă, M. and Zdrîncă, M. and Cavalu, S (2021) 'Evaluation of Wound Healing Potential of Novel Hydrogel Based on Ocimum basilicum and Trifolium pratense Extracts', Processes, 9(11), pp. 2096-2096. doi:10.3390/pr9112096 Preclinical
    https://doi.org/10.3390/pr9112096
  40. British Herbal Medicine Association (1996) 'British Herbal Pharmacopoeia'. Traditional / reference
    https://scholar.google.com/scholar?q=British%20Herbal%20Pharmacopoeia
  41. Hoffmann, D (2003) 'Medical Herbalism'. Traditional / reference
    https://scholar.google.com/scholar?q=Medical%20Herbalism
  42. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  43. Booth, N.L., Piersen, C.E., Banuvar, S., Geller, S.E., Shulman, L.P. and Farnsworth, N.R (2006) 'Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review', Menopause, 13(2), pp. 251-264. doi:10.1097/01.gme.0000198297.40269.f7 Meta-analysis / review
    https://doi.org/10.1097/01.gme.0000198297.40269.f7
  44. Fritz, H., Seely, D., Flower, G., Skidmore, B., Fernandes, R., Vadeboncoeur, S., Kennedy, D., Cooley, K., Wong, R., Sagar, S., Sabri, E. and Fergusson, D (2013) 'Soy, red clover, and isoflavones and breast cancer: a systematic review', PLoS One, 8(11), pp. e81968. doi:10.1371/journal.pone.0081968 Meta-analysis / review
    https://doi.org/10.1371/journal.pone.0081968

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.